(AOF) – Implanet announces the success of the capital increase in cash with maintenance of shareholders’ preferential subscription rights announced on January 4, 2024. The medtech specialist in spinal implants specifies that this operation made it possible to raise an amount of 5, 5 million euros through the issue of approximately 83.924 million new shares at a unit price of 0.0655 euros corresponding to the closing price on January 3. The gross proceeds will enable the company to finance its anticipated cash flow needs for the next 12 months.
At the end of the operation, Sanyou Medical, a company specializing in innovative orthopedic products, holds 74.56% of the capital and voting rights of Implanet, compared to 41.03% of the capital previously, the remaining float of 22. 33%. On October 31, 2023, Sanyou Medical obtained an exemption from the obligation to file a mandatory public purchase offer from the Financial Markets Authority (AMF).
The participation of a shareholder who held 1% of the company’s capital prior to the capital increase and who did not subscribe to it is reduced to 0.328%.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
